肺癌分期:简明更新
本文综述肺癌诊断与临床分期的技术流程,强调影像、内镜及微创手术应按侵入性递增顺序进行,术中系统淋巴结清扫对完整切除至关重要,病理分期是最强预后指标。文章整合了美国胸科医师学会与欧洲胸外科医师学会指南、肺腺癌新分类及第八版TNM分期。
要点
- 临床分期技术应按侵入性递增顺序进行:解剖与代谢影像、内镜、微创手术。
- 术中系统淋巴结清扫评估原发肿瘤范围及区域淋巴转移,对完整切除必不可少。
- 病理分期是切除肿瘤最强的预后指标,并指导后续治疗决策。
核心结论
- 肺癌临床分期技术应按侵入性递增顺序进行,术中系统淋巴结清扫对完整切除至关重要,病理分期是最强预后指标。
研究设计与样本
- 本文为综述,整合美国胸科医师学会与欧洲胸外科医师学会肺癌分期指南、肺腺癌新分类及第八版TNM分期。
主要发现
- 临床分期技术包括解剖与代谢影像、内镜及微创手术,应按侵入性递增顺序进行。
- 术中分期通过系统淋巴结清扫评估原发肿瘤大小、受累结构及区域淋巴转移,对完整切除必不可少。
- 切除肿瘤的病理分期是 strongest 预后指标,对后续治疗决策至关重要。
关键数值与推荐
- 肺腺癌新分类定义了原位腺癌、微浸润腺癌及贴壁为主型腺癌,需整合入分期过程。
- 第八版TNM分类已发布,需整合入分期过程。
临床怎么用
- 临床实践中应按侵入性递增顺序安排分期检查,术中行系统淋巴结清扫,切除后依据病理分期制定后续治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diagnosis and clinical staging of lung cancer are fundamental to planning therapy. The techniques for clinical staging, i.e anatomic and metabolic imaging, endoscopies and minimally invasive surgical procedures, should be performed sequentially and with an increasing degree of invasiveness. Intraoperative staging, assessing the magnitude of the primary tumour, the involved structures, and the loco-regional lymphatic spread by means of systematic nodal dissection, is essential in order to achieve a complete resection. In resected tumours, pathological staging, with the systematic study of the resected specimens, is the strongest prognostic indicator and is essential to make further decisions on therapy. In the present decade, the guidelines on lung cancer staging of the American College of Chest Physicians and the European Society of Thoracic Surgeons are based on the best available evidence and are widely followed. Recent advances in the classification of the adenocarcinoma of the lung, with the definition of adenocarcinoma in situ, minimally invasive adenocarcinoma and lepidic predominant adenocarcinoma, and the publication of the eighth edition of the tumour, node and metastasis classification of lung cancer, have to be integrated into the staging process. The present review complements the latest guidelines on lung cancer staging by providing an update of all these issues.
引用
- Rami-Porta R, Call S, Dooms C, et al. Lung cancer staging: a concise update. Eur Respir J. 2018. PMID: 29700105. doi:10.1183/13993003.00190-2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。